Schädigung von Gehirnzellen und Immunsystem durch Pfizer-Impfstoff (26.03.2022)

2 years ago
927

Potentially Reduced Brain Immunity Caused by Pfizer Vaccine (Polish In-vitro Preprint) - Schädigung von Gehirnzellen und Immunsystem durch Pfizer-Impfstoff (26.03.2022)

Drbeen Medical Lectures
558.000 Abonnenten
Potentially Reduced Brain Immunity Caused by Pfizer Vaccine (Polish In-vitro Preprint)

An in-vitro study from Poland finds reduced immune strength of the brain tissue cells when Pfizer-BionTech vaccine is used on them. Let's review.

If you like this content and want more, I am doing a special lifetime membership offer. Click here:
https://www.drbeen.com/yt-special/

Want to support this work?:
Buy me a coffee :-) https://www.buymeacoffee.com/DrMobeen...
Become my patron: https://www.patreon.com/mobeensyed?fa...
PayPal: https://paypal.me/mobeensyed?locale.x...

#drbeen #koolbeens #COVID

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
URL list from Monday, Mar. 21 2022 17:05 PM
To copy this list, type [Ctrl] A, then type [Ctrl] C.

DrBeen: Continuing Medical Education Online | USMLE Prep | CME and CE marketplace | Nurse Practitioner and Physician Assistant Training Programs | Medical Student Training
https://www.drbeen.com/

Decoding COVID-19 mRNA Vaccine Immunometabolism in Central Nervous System: human brain normal glial and glioma cells by Raman imaging | bioRxiv
https://www.biorxiv.org/content/10.11...

Decoding COVID-19 mRNA Vaccine Immunometabolism in Central Nervous System: human brain normal glial and glioma cells by Raman imaging
https://www.biorxiv.org/content/10.1101/2022.03.02.482639v1.full.pdf

Loading comments...